Availability, relative prices, and territorial inequality of essential medicines in Peru: a pharmaceutical surveillance analysis using official sources, 2020–2025
Background/Objectives National pharmaceutical surveillance can describe medicine availability and relative prices, but it cannot establish household affordability without treatment-cost and purchasing-power data. We assessed recorded availability, national relative prices, and territorial inequality of essential medicines in Peru during 2020–2025.Methods An ecological annual panel integrated 363,183 administrative records; 311,020 were classified as essential medicines. Descriptive analyses, two-way cluster-robust modified Poisson models, and sensitivity analyses addressed repeated observations, missing prices, unspecified care levels, and changes in the product basket.Results Median recorded availability increased from 85.4% in 2020–99.4% in 2025; the proportion below 80% decreased from 47.5% to 36.5%. Excluding unspecified care levels reduced the overall low-availability proportion from 44.9% to 27.4%. Prices were linked for 42.9% of essential-medicine records, and 9.6% of linked records had high relative prices. Low availability and high relative price co-occurred in 4.8% of linked records. Availability Gini declined from 0.082 to 0.037, whereas co-occurrence Gini was 0.262 in 2025 despite a lower mean co-occurrence burden. The East had higher adjusted low-availability prevalence than Center (aPR 1.20; 95% CI 1.08–1.34). Improvement after 2023 persisted in a balanced panel but was attenuated after excluding unspecified care levels.Conclusion Recorded availability improved, with substantial sensitivity to administrative composition. Incomplete and ingredient-level price linkage limits economic interpretation; the findings support targeted surveillance, not conclusions about patient affordability or causal policy effects.
Authors
- Victor Moreno-Prieto (ORCID: https://orcid.org/0000-0001-6118-0189)
- Junior F. Siguas-Peña (ORCID: https://orcid.org/0000-0002-1490-3206)
- María Andrea Serrano Boza (ORCID: https://orcid.org/0009-0004-1434-8646)
- Camila Alessandra Vasquez Ramirez (ORCID: https://orcid.org/0009-0001-1519-7366)
Institutions
- Universidad Norbert Wiener (PE)
Publication Details
- Journal
- Journal of Pharmaceutical Policy and Practice
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1080/20523211.2026.2761150
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00